Levin LA - Search Results

1

Feasibility and attractiveness of indication value-based pricing in key EU countries.

Flume M, Bardou M, Capri S, Sola-Morales O, Cunningham D, Levin LA, Touchot N; Payers’ Insight. Flume M, et al. Among authors: levin la. J Mark Access Health Policy. 2016 May 10;4. doi: 10.3402/jmahp.v4.30970. eCollection 2016. J Mark Access Health Policy. 2016. PMID: 27226845 Free PMC article. Review.

2

Approaches to manage 'affordability' of high budget impact medicines in key EU countries.

Flume M, Bardou M, Capri S, Sola-Morales O, Cunningham D, Levin LA, Postma MJ, Touchot N. Flume M, et al. Among authors: levin la. J Mark Access Health Policy. 2018 Jun 8;6(1):1478539. doi: 10.1080/20016689.2018.1478539. eCollection 2018. J Mark Access Health Policy. 2018. PMID: 29915664 Free PMC article. Review.

3

Ethical Hurdles in the Prioritization of Oncology Care.

de Groot F, Capri S, Castanier JC, Cunningham D, Flamion B, Flume M, Herholz H, Levin LÅ, Solà-Morales O, Rupprecht CJ, Shalet N, Walker A, Wong O. de Groot F, et al. Among authors: levin la. Appl Health Econ Health Policy. 2017 Apr;15(2):119-126. doi: 10.1007/s40258-016-0288-4. Appl Health Econ Health Policy. 2017. PMID: 27766548 Free PMC article.

4

Centrality and compatibility of institutional logics when introducing value-based reimbursement.

Eriksson T, Levin LÅ, Nedlund AC. Eriksson T, et al. Among authors: levin la. J Health Organ Manag. 2021 Sep 15;35(9):298-314. doi: 10.1108/JHOM-01-2021-0010. J Health Organ Manag. 2021. PMID: 34535988 Free PMC article.

5

Including Both Costs and Effects--The Challenge of Using Cost-Effectiveness Data in National-Level Policy-Making: A Response to Recent Commentaries.

Eckard N, Janzon M, Levin LÅ. Eckard N, et al. Among authors: levin la. Int J Health Policy Manag. 2015 Jul 8;4(8):565-6. doi: 10.15171/ijhpm.2015.123. Int J Health Policy Manag. 2015. PMID: 26340402 Free PMC article. No abstract available.

6

Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden.

Eckard N, Janzon M, Levin LÅ. Eckard N, et al. Among authors: levin la. Int J Health Policy Manag. 2014 Oct 27;3(6):323-32. doi: 10.15171/ijhpm.2014.105. eCollection 2014 Nov. Int J Health Policy Manag. 2014. PMID: 25396208 Free PMC article.

7

Is the societal approach wide enough to include relatives? Incorporating relatives' costs and effects in a cost-effectiveness analysis.

Davidson T, Levin LA. Davidson T, et al. Among authors: levin la. Appl Health Econ Health Policy. 2010;8(1):25-35. doi: 10.1007/BF03256163. Appl Health Econ Health Policy. 2010. PMID: 20038191

8

Utilization and costs of glucose lowering therapies following health technology assessment for the new reimbursement scheme in Sweden.

Pettersson B, Hoffmann M, Andersson D, Wändell P, Levin LÅ. Pettersson B, et al. Among authors: levin la. Health Policy. 2012 Dec;108(2-3):207-15. doi: 10.1016/j.healthpol.2012.10.008. Epub 2012 Nov 8. Health Policy. 2012. PMID: 23140907

9

Effects of eating breakfast on children and adolescents: A systematic review of potentially relevant outcomes in economic evaluations.

Lundqvist M, Vogel NE, Levin LÅ. Lundqvist M, et al. Among authors: levin la. Food Nutr Res. 2019 Sep 12;63. doi: 10.29219/fnr.v63.1618. eCollection 2019. Food Nutr Res. 2019. PMID: 31548838 Free PMC article. Review.

10

A pain relieving reimbursement program? Effects of a value-based reimbursement program on patient reported outcome measures.

Eriksson T, Tropp H, Wiréhn AB, Levin LÅ. Eriksson T, et al. Among authors: levin la. BMC Health Serv Res. 2020 Aug 27;20(1):805. doi: 10.1186/s12913-020-05578-8. BMC Health Serv Res. 2020. PMID: 32847579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page